Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis

Hypersensitivity pneumonitis (HP) is a diffuse interstitial lung disease (ILD) caused by the inhalation of a variety of antigens in susceptible individuals. Patients with fibrotic HP (fHP) may show histopathological and radiological manifestations similar to patients with idiopathic pulmonary fibros...

Full description

Bibliographic Details
Main Authors: Paolo Giannoni, Marco Grosso, Giuseppina Fugazza, Mario Nizzari, Maria Cristina Capra, Rita Bianchi, Roberto Fiocca, Sandra Salvi, Fabrizio Montecucco, Maria Bertolotto, Franco Fais, Mario Salio, Emanuela Barisione, Daniela de Totero
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/9/1193
_version_ 1797520145249206272
author Paolo Giannoni
Marco Grosso
Giuseppina Fugazza
Mario Nizzari
Maria Cristina Capra
Rita Bianchi
Roberto Fiocca
Sandra Salvi
Fabrizio Montecucco
Maria Bertolotto
Franco Fais
Mario Salio
Emanuela Barisione
Daniela de Totero
author_facet Paolo Giannoni
Marco Grosso
Giuseppina Fugazza
Mario Nizzari
Maria Cristina Capra
Rita Bianchi
Roberto Fiocca
Sandra Salvi
Fabrizio Montecucco
Maria Bertolotto
Franco Fais
Mario Salio
Emanuela Barisione
Daniela de Totero
author_sort Paolo Giannoni
collection DOAJ
description Hypersensitivity pneumonitis (HP) is a diffuse interstitial lung disease (ILD) caused by the inhalation of a variety of antigens in susceptible individuals. Patients with fibrotic HP (fHP) may show histopathological and radiological manifestations similar to patients with idiopathic pulmonary fibrosis (usual interstitial pneumonia-like pattern of fibrosis) that are associated with a worse prognosis. We describe here the establishment and characterization of a fibroblastic cell line derived from the broncho-alveolar lavage (BAL) of a patient with fHP, a 53 year old man who presented at our Pneumology Unit with cough and dyspnea. The fHP diagnosis was based on international criteria and multidisciplinary discussion. Primary fibroblasts were expanded in vitro until passage 36. These fibroblasts displayed morpho/phenotypical features of myofibroblasts, showing high positivity for α-smooth muscle actin, type I collagen, and fibronectin as determined by quantitative RT-PCR and cyto-fluorographic analysis. Cytogenetic analyses further evidenced trisomy of chromosome 10, which interestingly harbors the FGF2R gene. To our knowledge, this is the first fibroblastic cell line derived from an fHP patient and might, therefore, represent a suitable tool to model the disease in vitro. We preliminarily assessed here the activity of pirfenidone, further demonstrating a consistent inhibition of cells growth by this antifibrotic drug.
first_indexed 2024-03-10T07:52:41Z
format Article
id doaj.art-d29167c2d89b4aeb9362d9febf589267
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T07:52:41Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-d29167c2d89b4aeb9362d9febf5892672023-11-22T12:08:25ZengMDPI AGBiomedicines2227-90592021-09-0199119310.3390/biomedicines9091193Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity PneumonitisPaolo Giannoni0Marco Grosso1Giuseppina Fugazza2Mario Nizzari3Maria Cristina Capra4Rita Bianchi5Roberto Fiocca6Sandra Salvi7Fabrizio Montecucco8Maria Bertolotto9Franco Fais10Mario Salio11Emanuela Barisione12Daniela de Totero13Department Experimental Medicine, University of Genoa, 16132 Genoa, ItalyInterventional Pulmonary Unit, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, ItalyDepartment Internal Medicine and Medical Specialties, University of Genoa, 16132 Genoa, ItalyDepartment Internal Medicine and Centre of Excellence for Biomedical Research, University of Genoa, 16132 Genoa, ItalyMolecular Pathology Unit, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, ItalyAnatomic Pathology Unit, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, ItalyAnatomic Pathology Unit, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, ItalyAnatomic Pathology Unit, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, ItalyDepartment Internal Medicine and Medical Specialties, University of Genoa, 16132 Genoa, ItalyDepartment Internal Medicine and Medical Specialties, University of Genoa, 16132 Genoa, ItalyDepartment Experimental Medicine, University of Genoa, 16132 Genoa, ItalyS.C. Malattie Apparato Respiratorio, Azienda Ospedaliera Nazionale Antonio, Biagio e Cesare Arrigo, 15121 Alessandria, ItalyInterventional Pulmonary Unit, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, ItalyMolecular Pathology Unit, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, 16132 Genoa, ItalyHypersensitivity pneumonitis (HP) is a diffuse interstitial lung disease (ILD) caused by the inhalation of a variety of antigens in susceptible individuals. Patients with fibrotic HP (fHP) may show histopathological and radiological manifestations similar to patients with idiopathic pulmonary fibrosis (usual interstitial pneumonia-like pattern of fibrosis) that are associated with a worse prognosis. We describe here the establishment and characterization of a fibroblastic cell line derived from the broncho-alveolar lavage (BAL) of a patient with fHP, a 53 year old man who presented at our Pneumology Unit with cough and dyspnea. The fHP diagnosis was based on international criteria and multidisciplinary discussion. Primary fibroblasts were expanded in vitro until passage 36. These fibroblasts displayed morpho/phenotypical features of myofibroblasts, showing high positivity for α-smooth muscle actin, type I collagen, and fibronectin as determined by quantitative RT-PCR and cyto-fluorographic analysis. Cytogenetic analyses further evidenced trisomy of chromosome 10, which interestingly harbors the FGF2R gene. To our knowledge, this is the first fibroblastic cell line derived from an fHP patient and might, therefore, represent a suitable tool to model the disease in vitro. We preliminarily assessed here the activity of pirfenidone, further demonstrating a consistent inhibition of cells growth by this antifibrotic drug.https://www.mdpi.com/2227-9059/9/9/1193hypersensitivity pneumonitisfibrosismyofibroblastspirfenidone
spellingShingle Paolo Giannoni
Marco Grosso
Giuseppina Fugazza
Mario Nizzari
Maria Cristina Capra
Rita Bianchi
Roberto Fiocca
Sandra Salvi
Fabrizio Montecucco
Maria Bertolotto
Franco Fais
Mario Salio
Emanuela Barisione
Daniela de Totero
Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis
Biomedicines
hypersensitivity pneumonitis
fibrosis
myofibroblasts
pirfenidone
title Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis
title_full Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis
title_fullStr Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis
title_full_unstemmed Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis
title_short Establishment and Characterization of a Novel Fibroblastic Cell Line (SCI13D) Derived from the Broncho-Alveolar Lavage of a Patient with Fibrotic Hypersensitivity Pneumonitis
title_sort establishment and characterization of a novel fibroblastic cell line sci13d derived from the broncho alveolar lavage of a patient with fibrotic hypersensitivity pneumonitis
topic hypersensitivity pneumonitis
fibrosis
myofibroblasts
pirfenidone
url https://www.mdpi.com/2227-9059/9/9/1193
work_keys_str_mv AT paologiannoni establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT marcogrosso establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT giuseppinafugazza establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT marionizzari establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT mariacristinacapra establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT ritabianchi establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT robertofiocca establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT sandrasalvi establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT fabriziomontecucco establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT mariabertolotto establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT francofais establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT mariosalio establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT emanuelabarisione establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis
AT danieladetotero establishmentandcharacterizationofanovelfibroblasticcelllinesci13dderivedfromthebronchoalveolarlavageofapatientwithfibrotichypersensitivitypneumonitis